Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $129.60 on ICU Medical, Inc. (NASDAQ:ICUI) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $4.43 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of ICU Medical, Inc. (NASDAQ:ICUI) stands at 36.69. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For ICU Medical, Inc., the PEG ratio for coming 3-5 years is 2.79. Technical Analysis The technical analysis highlights that ICU Medical, Inc. current price is trading $3.71 points away +3.38% from $109.59, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $101.23 and, for now, the stock price is trading $12.07 or +11.92% away from that point. The 52-week high of ICU Medical, Inc. (NASDAQ:ICUI) was $124.69 while lowest point recorded in 52-week was $85.56. It implies if stock price makes a movement of over $-11.39, it will record a new 52-week high. In the case of $+32.42% points drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know